causal
Pharma Patents Block Competitors by Cost
In pharma, a competitor must find another needle in the haystack and spend as much on R&D as the first discoverer, so an incumbent already in the market can keep rivals out in a way software patents cannot.
causalpending
Speaker
JerryEvidence Quote
“So they have to spend as much money on R and D as you did, and you're already in the market, so you can keep them out.”
Created: 11/20/2026, 2:41:09 AM
Your notes
Loading notes...